Prashant Sakharkar

Associate Professor and Director of Graduate Program, Department of Clinical and Administrative Sciences
Pharm.D., M.P.H.
Office: 2306
Phone: 305-760-7467
Hours: By Appointment

Education and Training

  • PharmD | Pharmacy | University of Florida, College of Pharmacy, Gainesville, FL
  • MPH | Health Policy and Management | University of Florida, College of Public Health and Health Professions, Gainesville, FL
  • Post-Doctoral Fellowship | Health Outcomes Research | Western University of Health Sciences, College of Pharmacy, Pomona, CA


Teaching Interests:

Dr. Sakharkar’s teaching interest and experience spans a range of subjects, including research methods, statistics, epidemiology, pharmacoeconomics, health outcomes assessment, and health policy.


Scholarly Interests:

Dr. Sakharkar’s research is focused on economic analyses of drug therapy and pharmaceutical care. His research further extends to secondary database analysis and exploring health outcomes in renal transplant patients. Additionally, he delves into patient-reported outcomes and contributes to the policy evaluation of health programs and healthcare services.


Dr. Sakharkar is the Director of the Graduate Program in Social and Administrative Sciences and an Associate Professor in the Department of Clinical and Administrative Sciences at Larkin University College of Pharmacy. Before joining Larkin, he was a tenured associate professor at Roosevelt University College of Pharmacy.


Dr. Sakharkar is well-published with contributions to peer-reviewed international journals and has presented at national and international conferences. He plays a crucial role as a reviewer for many pharmacy and healthcare research journals. Notably, he received recognition as an outstanding reviewer from the Journal of American Pharmacists Association (JAPhA) and Research in Social and Administrative Pharmacy (RSAP). He has also served on the editorial advisory board of JAPhA.

Selected Publications


Sakharkar P, Kurup S. Comparing Efficacy of Erlotinib and Bevacizumab Combination with Erlotinib Monotherapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-analysis. Diseases 2023, 11 (4), 146.

Luu D, Shah T, Sakharkar P, Min DI. Genetic variations in a Sestrin2/Sestrin3/mTOR Axis and development of new-onset diabetes after kidney transplantation. Transplant Immunology 2023 , 81,101947.


Sakharkar P, Ansari N. Application of Exploratory Factor Analysis and Item Response Theory to Validate NHANES ADL Scale in Patients Reporting Rheumatoid Arthritis. Pharmacy 2022, 10, 138.


Sakharkar P, Friday Kafi. Examining Health Disparities and Severity of Depression among Sexual Minorites in a National Population Sample. Diseases 2022, 10, 86.


Sakharkar P, Mai Thanh. Co-Occurring Depression and Associated Healthcare Utilization and Expenditure in Individuals with Respiratory Condition: A Population-Based Study. Pharmacy 2021, 9(4): 157.


Sakharkar P, Deb S. A Population Based Study of Liver Function amongst Adults with Hyperuricemia and Gout in the United States. Diseases 2021, 9(3): 61.


Sakharkar P, Deb S. Examining Liver Function in Adults with Diabetes in the United States. J Pharm Pharm Sci (JPPS) 2021, 23 (3): 317-328.


Majerczyk D, Rusche K, Sakharkar P. Assessment of Time in Therapeutic Range with Warfarin Therapy in Pharmacist versus Usual Care Group: A Retrospective Cohort Study. Asian J Pharm Clin Res 2020, 13 (7), 68-71.


Sakharkar P, Deb S, Mashayekhi N. Association between Polymorphisms in Cytokine Gene and Viral Infections in Renal and Liver Transplant Recipients: A Systematic Review. J Pharm Pharm Sci (JPPS) 2020, 23, 109-131.


Deb S, Puthanveetil, Sakharkar P. A Population-Based Cross-Sectional Study of the Association between Liver Enzymes and Lipid Levels. Int J Hepatology, Vol. 2018, Article ID 1286170, 8 pages.


Sakharkar P. Draft National Health Policy of India and Determining Cost-effectiveness Threshold. J Basic Clin Pharm. 2016 Dec; 8 (1):1-3. doi: 10.4103/0976-0105.195078.


Sakharkar P, Bounthavong M, Hirsch JD, Morello CM, Chen TC, Law AV. Development and validation of PSPSQ 2.0 measuring patient satisfaction with pharmacist services. Res Soc Admin Pharm 2015, 11 (4): 487-98.


Law Anandi V, Sakharkar P, Zargarzadeh Amir, Tai Bik Bilvick, Hess Karl, Hata Micah, Mireles Rudolph, Ha Carolyn, Park Tony J. Taking stock of medication wastage: Unused medications in US households. Res Soc Admin Pharm. 2015, Vol. 11 (4): 571-78.


Vu D, Shah T, Ansari J, Sakharkar P, Yasir Q, Naraghi R, Hutchinson I, Min D. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients. Transpl Infect Dis. 2014; 16(5):724-32. doi: 10.1111/tid.12285.


Vu D, Sakharkar P, Shah T, Naraghi R, Yasir Q, Hutchinson I, Min D. Association of interferon gamma gene polymorphisms with BK virus infection among Hispanic renal allograft recipients. Transplantation 2014, Vol. 97 (6):660-667.


Sakharkar P, Zargarzadeh A, Law AV. Examining Preference of Elderly for Indication on Prescription Label (Rx Label). Eur J Pers Cent Healthc. 2014; 2(4): 523-32. doi:


Schwartzman Emmanuelle, Chung Eunice, Sakharkar P, Law Anandi V. Instruction, and assessment of student communication skills in US and Canadian pharmacy curricula. Curr Pharm Teach Learn 2013, Vol. 5 (6): 508-517.


Vu D, Tellez-Corrales E, Sakharkar P, Kissen MS, Shah T, Hutchinson I, Min DI. Impact of NF-κB gene polymorphism on allograft outcome in Hispanic renal transplant recipients. Transpl Immunol. 2013;28(1):18-23. doi: 10.1016/j.trim.2012.11.001.

Vu D, Sakharkar P, Tellez-Corrales E, Shah T, Hutchinson I, Min DI. Association of vitamin D binding protein polymorphism with long-term kidney allograft survival in Hispanic kidney transplant recipients. Mol Biol Rep. 2013; 40(2):933-9. doi: 10.1007/s11033-012-2134-6.